-
STAT+: Colombia issues a compulsory license for an HIV medicine and ‘plants a flag for global health equity’
25 Apr 2024 04:17 GMT
… compulsory license for an HIV medicine, the first time … sold by ViiV Healthcare, a company that specializes in HIV treatments and … is largely controlled by GSK. Dolutegravir … for people living with HIV.
A compulsory license allows …
-
New treatments on the horizon could curb the HIV fight | Healthy SA
24 Apr 2024 13:28 GMT
… at ViiV Healthcare say even though many people believe the HIV epidemic … Garges, chief medical officer for ViiV Healthcare.
Garges is referring to … to everyone impacted by HIV is necessary to end … says anyone living with HIV should talk to their physician …
-
Long-acting drugs may revolutionize HIV prevention and treatment
19 Apr 2024 10:07 GMT
… executive director of the HIV prevention organization AVAC.
Long … HIV worldwide were not receiving treatment. About 630,000 died from AIDS … , made by ViiV Healthcare (majority owned by GSK), and Janssen’ … the greatest in the AIDS response over the last …
-
ViiV Healthcare Receives FDA Approval for Dovato for Adolescents
08 Apr 2024 15:55 GMT
… HIV.
04.08.24
ViiV Healthcare, a specialist HIV company majority owned by GSK, with Pfizer … -years old living with HIV and underscores ViiV Healthcare’s ongoing commitment to … treatment. As a leader in HIV, ViiV Healthcare is proud of our focused …
-
ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV
08 Apr 2024 12:36 GMT
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as … deeper and broader interest in HIV and AIDS than any company has …
-
HIV Drugs Market To Surpass USD 43.06 Billion By 2031, Fueled With Expanding Treatment Programs
16 Apr 2024 17:07 GMT
… .
List of HIV Drugs Market Companies Profiled in Report:
→ViiV Healthcare,
→Gilead Sciences … in the HIV drug market. Top-notch healthcare, high HIV/AIDS awareness, and … due to its advanced healthcare, high HIV/AIDS awareness, and focus on …
-
FDA Approves Dovato for Teens Living With HIV
15 Apr 2024 13:47 GMT
… Food and Drug Administration approved ViiV Healthcare’s Dovato (dolutegravir… all-in-one daily HIV treatment option for adolescents … adolescents living with HIV, providing a complete HIV therapy with … 2019 for adults starting HIV treatment for the first …
-
YONECO in fight against GBV, HIV/AIDS among youths
11 Apr 2024 13:19 GMT
… to the increase of HIV/AIDS cases.
Executive Director … issues of GBV and HIV/AIDS by training community … to Sexual Reproductive issues, HIV and AIDS information, treatment, and … receiving financial support from ViiV Healthcare -Positive Action in the …
-
Outcome of Darunavir–Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological Failure
10 Apr 2024 07:10 GMT
… educational materials from Gilead Sciences, ViiV Healthcare, Janssen-Cilag, Merck Sharp … alafenamide in treatment-naive HIV-1 patients. AIDS. 2020;34(5):707 … alafenamide in treatment-naive HIV-1 patients. AIDS. 2018;32(11):1431 …
-
FDA Approves HIV Therapy for Adolescents
08 Apr 2024 21:39 GMT
… /lamivudine (Dovato, ViiV Healthcare) for adolescents living with HIV. This therapy becomes … approval coincides with National Youth HIV and AIDS Awareness Day, highlighting the … clinically significant.1
National Youth HIV and AIDS Awareness Day
This FDA …